Work

Abstract 893: A novel approach to treating HER2-low breast cancer: surface-engineered NK/tz cells targeted immunotherapy

Year: 2025
Type: conference-abstract
Language: English
Subfield: Immunology
Open Access status: closed
OpenAlex ID: W4409690013
Cites:
Cited by:
Related to: 10